Prognostic value of serum tenascin-C levels on long-term outcome after acute myocardial infarction

Journal of Cardiac Failure

Volumn 18, Issue 6, 2012, Pages 480-486

  Sato, Akira ^a   Hiroe, Michiaki ^b   Akiyama, Daiki ^c   Hikita, Hiroyuki ^c   Nozato, Toshihiro ^c   Hoshi, Tomoya ^a   Kimura, Taizo ^a   Wang, Zheng ^a   Sakai, Satoshi ^a   Imanaka Yoshida, Kyoko ^d   Yoshida, Toshimichi ^d   Aonuma, Kazutaka ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c YOKOSUKA KYOSAI HOSPITAL   (Japan)

^d MIE UNIVERSITY   (Japan)

Author keywords

B type natriuretic peptide; matricellular protein; myocardial infarction; prognosis; Tenascin C

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; TENASCIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DISEASE EXACERBATION; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; HEART DEATH; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; THORAX PAIN;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; DEATH; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; ROC CURVE; TENASCIN;

EID: 84862790333     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.02.009     Document Type: Article

References (32)

1. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
2. M.A. Pfeffer, and E. Braunwald Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1990 1161 1172
3. A.M. Richards, M.G. Nicholls, E.A. Epsiner, J.G. Lainchbury, R.W. Troughton, and J. Elliott B-Type natriuretic peptides and ejection fraction for prognosis after acute myocardial infarction Circulation 107 2003 2786 2792
4. S. Suzuki, M. Yoshimura, M. Nakayama, Y. Mizuno, E. Harada, and T. Ito Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis Circulation 110 2004 1387 1391
5. H. Steen, E. Giannitsis, S. Futterer, C. Merten, C. Juenger, and H.A. Katus Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function J Am Coll Cardiol 48 2006 2192 2194
6. S. Chia, F. Senatore, O.C. Raffel, H. Lee, F.J. Wackers, and I.K. Jang Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction JACC Cardiovasc Interv 1 2008 415 423
7. T. Anzai, T. Yoshikawa, H. Shiraki, Y. Asakura, M. Akaishi, and H. Mitamura C-Reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction Circulation 96 1997 778 784
8. D.R. Wagner, C. Delagardelle, I. Ernens, D. Rouy, M. Vaillant, and J. Beissel Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction J Card Fail 12 2006 66 72
9. W.H. Tang, G.S. Francis, D.A. Morrow, L.K. Newby, C.P. Cannon, R.L. Jesse National Academy of Clinical Biochemistry Laboratory Medicine National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure Clin Biochem 41 2008 210 221
10. S. Jane-Lise, S. Corda, C. Chassagne, and L. Rappaport The extracellular matrix and the cytoskeleton in heart hypertrophy and failure Heart Fail Rev 5 2000 239 250
11. K. Imanaka-Yoshida, M. Hiroe, T. Nishikawa, S. Ishiyama, T. Shimojo, and Y. Ohta Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction Lab Invest 81 2001 1015 1024
12. A. Sato, K. Aonuma, K. Imanaka-Yoshida, T. Yoshida, M. Isobe, and D. Kawase Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction J Am Coll Cardiol 47 2006 2319 2325
13. N.G. Frangogiannis, S. Shimoni, S. Chang, G. Ren, O. Dewald, and C. Gersch Active interstitial remodeling: an important process in the hibernating human myocardium J Am Coll Cardiol 39 2002 1468 1474
14. K. Imanaka-Yoshida, M. Hiroe, Y. Yasutomi, T. Toyozaki, T. Tsuchiya, and N. Noda Tenascin-C is a useful marker for disease activity in myocarditis J Pathol 197 2002 388 394
15. S. Morimoto, K. Imanaka-Yoshida, S. Hiramitsu, S. Kato, M. Ohtsuki, and A. Uemura Diagnostic utility of tenascin-C for evaluation of the activity of human acute myocarditis J Pathol 205 2005 460 467
16. F. Terasaki, H. Okamoto, K. Onishi, A. Sato, H. Shimomura, B. Tsukada Study Group for Intractable Diseases by a Grant from the Ministry of Health, Labor and Welfare of Japan Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy Circ J 71 2007 327 330
17. N. Fujimoto, K. Onishi, A. Sato, F. Terasaki, B. Tsukada, and T. Nozato Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure J Card Fail 15 2009 898 905
18. TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings N Engl J Med 312 1985 932 936
19. G. Orend, and R. Chiquet-Ehrismann Tenascin-C induced signaling in cancer Cancer Lett 244 2006 143 163
20. G. Orend Potential oncogenic action of tenascin-C in tumorigenesis Int J Biochem Cell Biol 37 2005 1066 1083
21. M. Hasegawa, H. Hirata, A. Sudo, K. Kato, D. Kawase, and N. Kinoshita Tenascin-C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis J Rheumatol 31 2004 2021 2026
22. S. Matsuo, E. Imai, M. Horio, Y. Yasuda, K. Tomita, and K. Nitta Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
23. M.J. Pencina, R.B. d'Agostino Sr., R.B. d'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
24. T. Nishioka, K. Onishi, N. Shimojo, Y. Nagano, M. Ikeuchi, and T. Ide Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice Am J Physiol Heart Circ Physiol 298 2010 H1072 H1078
25. D. Kelly, S.Q. Khan, M. Thompson, G. Cockerill, L.L. Ng, and N. Samani Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodeling and prognosis after acute myocardial infarction Eur Heart J 29 2008 2116 2124
26. I.E. Willems, J.W. Arends, and M.J. Daemen Tenascin and fibronectin expression in healing human myocardial scars J Pathol 179 1996 321 325
27. A.H. Baker, D.R. Edwards, and G. Murphy Metalloproteinase inhibitors: biological actions and therapeutic opportunities J Cell Sci 115 2002 3719 3727
28. M. Tamaoki, K. Imanaka-Yoshida, K. Yokoyama, T. Nishioka, H. Inada, and M. Hiroe Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury Am J Pathol 167 2005 71 80
29. G.L. Smith, F.A. Masoudi, M.G. Shlipak, H.M. Krumholz, and C.R. Parikh Renal impairment predicts long-term mortality risk after acute myocardial infarction J Am Soc Nephrol 19 2008 141 150
30. K. Damman, G. Navis, A.A. Voors, F.W. Asselbergs, T.D. Smilde, and J.G. Cleland Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 2007 599 608
31. J.H. Hörstrup, M. Gehrmann, B. Schneider, A. Plöger, P. Froese, and T. Schirop Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease Nephrol Dial Transplant 17 2002 1005 1013
32. A.S. Jaffe, L. Babuin, and F.S. Apple Biomarkers in acute cardiac disease: the present and the future J Am Coll Cardiol 48 2006 1 11